PTC Therapeutics to Participate at Upcoming Investor Conferences
PTC Therapeutics, Inc. (NASDAQ: PTCT) has announced its participation in three upcoming investor conferences in September 2024.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
PTC Therapeutics, Inc. (NASDAQ: PTCT) has announced its participation in three upcoming investor conferences in September 2024. The company will present overviews at:
- Morgan Stanley 22nd Annual Global Healthcare Conference on Sept. 5 at 9:15 am ET
- 2024 Wells Fargo Healthcare Conference on Sept. 6 at 12:00 pm ET
- Cantor 2024 Global Healthcare Conference on Sept. 17 at 2:30 pm ET
All presentations will be webcast live on PTC Therapeutics' website under the Investor section's Events and Presentations page. The webcasts will remain archived for 30 days after each presentation. Investors are advised to connect to the website several minutes before the start of each webcast to ensure timely access.
Details
News Market Reaction – PTCT
The recorded move for PTCT in the trading session of this news was +0.97%.
Data tracked by StockTitan Argus. Session date unavailable.
AI-generated analysis. How Rhea-AI works. Not financial advice.
Morgan Stanley 22nd Annual Global Healthcare Conference
Thursday, Sept. 5 at 9:15 am ET
2024 Wells Fargo Healthcare Conference
Friday, Sept. 6 at 12:00 pm ET
Cantor 2024 Global Healthcare Conference
Tuesday, Sept. 17 at 2:30 pm ET
The presentations will be webcast live on the Events and Presentations page under the Investor section of PTC Therapeutics' website at https://ir.ptcbio.com/events-presentations and will be archived for 30 days following the presentation. It is recommended that users connect to PTC's website several minutes prior to the start of the webcast to ensure a timely connection.
About PTC Therapeutics, Inc.
PTC is a global biopharmaceutical company focused on the discovery, development and commercialization of clinically differentiated medicines that provide benefits to patients with rare disorders. PTC's ability to globally commercialize products is the foundation that drives investment in a robust and diversified pipeline of transformative medicines and our mission to provide access to best-in-class treatments for patients who have an unmet medical need. The company's strategy is to leverage its strong scientific expertise and global commercial infrastructure to maximize value for its patients and other stakeholders. To learn more about PTC, please visit us at www.ptcbio.com and follow us on Facebook, on X (formerly Twitter), and on LinkedIn.
For More Information:
Investors:
Investor Relations
+1 (908) 912-9848
ir@ptcbio.com
Media:
Jeanine Clemente
+1 (908) 912-9406
jclemente@ptcbio.com
View original content:https://www.prnewswire.com/news-releases/ptc-therapeutics-to-participate-at-upcoming-investor-conferences-302233405.html
SOURCE PTC Therapeutics, Inc.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.